Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders

References

Abe, H., Hisaoka-Nakashima, K., Kajitani, N., Okada-Tsuchioka, M., Yano, R., Itagaki, K., Shibasaki, C., Morioka, N., Nakata, Y., and Takebayashi, M. (2016). The expression of glial cell line-derived neurotrophic factor mRNA by antidepressants involves matrix metalloproteinase-9 activation in rat astroglial cells. Biochem. Biophys. Res. Commun. 479, 907–912.10.1016/j.bbrc.2016.09.070Search in Google Scholar

Airaksinen, M.S. and Saarma, M. (2002). The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383–394.10.1038/nrn812Search in Google Scholar

Allen, S.J., Watson, J.J., Shoemark, D.K., Barua, N.U., and Patel, N.K. (2013). GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol. Ther. 138, 155–175.10.1016/j.pharmthera.2013.01.004Search in Google Scholar

Andressoo, J.O. and Saarma, M. (2008). Signalling mechanisms underlying development and maintenance of dopamine neurons. Curr. Opin. Neurobiol. 18, 297–306.10.1016/j.conb.2008.07.005Search in Google Scholar

Angelucci, F., Aloe, L., Jiménez-Vasquez, P., and Mathé, A.A. (2002). Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J. ECT 18, 138–143.10.1097/00124509-200209000-00005Search in Google Scholar

Angelucci, F., Aloe, L., Jiménez-Vasquez, P., and Mathé, A.A. (2003). Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int. J. Neuropsychopharmacol. 6, 225–231.10.1017/S1461145703003468Search in Google Scholar

Antonelli, T., Ferioli, V., Lo Gallo, G., Tomasini, M.C., Fernandez, M., O’Connor, W.T., Glennon, J.C., Tanganelli, S., and Ferraro, L. (2000). Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat. Synapse 38, 355–362.10.1002/1098-2396(20001201)38:3<355::AID-SYN15>3.0.CO;2-ESearch in Google Scholar

Arenas, E., Trupp, M., Akerud, P., and Ibáñez, C.F. (1995). GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465–1473.10.1016/0896-6273(95)90024-1Search in Google Scholar

Autry, A.E. and Monteggia, L.M. (2012). Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64, 238–258.10.1124/pr.111.005108Search in Google Scholar

Barbosa, I.G., Huguet, R.B., Sousa, L.P., Abreu, M.N., Rocha, N.P., Bauer, M.E., Carvalho, L.A., and Teixeira, A.L. (2011). Circulating levels of GDNF in bipolar disorder. Neurosci. Lett. 502, 103–106.10.1016/j.neulet.2011.07.031Search in Google Scholar

Bobak, M., Pikhart, H., Pajak, A., Kubinova, R., Malyutina, S., Sebakova, H., Topor-Madry, R., Nikitin, Y., and Marmot, M. (2006). Depressive symptoms in urban population samples in Russia, Poland and the Czech Republic. Br. J. Psychiatry 188, 359–365.10.1192/bjp.188.4.359Search in Google Scholar

Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Nielsen, M.G., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M.A., et al. (2010). Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatry 11, 763–773.10.3109/15622971003611319Search in Google Scholar

Bozzi, Y. and Borrelli, E. (1999). Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas. Eur. J. Neurosci. 11, 1275–1284.10.1046/j.1460-9568.1999.00541.xSearch in Google Scholar

Brunoni, A.R., Machado-Vieira, R., Zarate, C.A. Jr., Vieira, E.L., Valiengo, L., Benseñor, I.M., Lotufo, P.A., Gattaz, W.F., and Teixeira, A.L. (2015). Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 56, 91–96.10.1016/j.pnpbp.2014.08.009Search in Google Scholar

Capani, F., Quarracino, C., Caccuri, R., and Sica, R.E. (2016). Astrocytes as the main players in primary degenerative disorders of the human central nervous system. Front. Aging Neurosci. 8, 45.10.3389/fnagi.2016.00045Search in Google Scholar

Castro, L.M., Gallant, M., and Niles, L.P. (2005). Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J. Neurochem. 95, 1227–1236.10.1111/j.1471-4159.2005.03457.xSearch in Google Scholar

Catena-Dell’Osso, M., Fagiolini, A., Rotella, F., Baroni, S., and Marazziti, D. (2013). Glutamate system as target for development of novel antidepressants. CNS Spectrosc. 18, 188–198.10.1017/S1092852912000971Search in Google Scholar

Caumont, A.S., Octave, J.N., and Hermans, E. (2006). Specific regulation of rat glial cell line-derived neurotrophic factor gene expression by riluzole in C6 glioma cells. J. Neurochem. 97, 128–139.10.1111/j.1471-4159.2006.03711.xSearch in Google Scholar

Chen, A.C., Eisch, A.J., Sakai, N., Takahashi, M., Nestler, E.J., and Duman, R.S. (2001). Regulation of GFRα-1 and GFRα-2 mRNAs in rat brain by electroconvulsive seizure. Synapse 39, 42–50.10.1002/1098-2396(20010101)39:1<42::AID-SYN6>3.0.CO;2-#Search in Google Scholar

Chen, P.S., Peng, G.S., Li, G., Yang, S., Wu, X., Wang, C.C., Wilson, B., Lu, R.B., Gean, P.W., Chuang, D.M., et al. (2006). Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol. Psychiatry 11, 1116–1125.10.1038/sj.mp.4001893Search in Google Scholar

Czéh, B. and Di Benedetto, B. (2013). Antidepressants act directly on astrocytes: evidences and functional consequences. Eur. Neuropsychopharmacol. 23, 171–185.10.1016/j.euroneuro.2012.04.017Search in Google Scholar PubMed

Day, J.S., O’Neill, E., Cawley, C., Aretz, N.K., Kilroy, D., Gibney, S.M., Harkin, A., and Connor T.J. (2014). Noradrenaline acting on astrocytic β₂-adrenoceptors induces neurite outgrowth in primary cortical neurons. Neuropharmacology 77, 234–248.10.1016/j.neuropharm.2013.09.027Search in Google Scholar PubMed

de Azevedo Cardoso, T., Mondin, T.C., Wiener, C.D., Marques, M.B., Fucolo Bde, Á., Pinheiro, R.T., de Souza, L.D., da Silva, R.A., Jansen, K., and Oses, J.P. (2014). Neurotrophic factors, clinical features and gender differences in depression. Neurochem. Res. 39, 1571–1578.10.1007/s11064-014-1349-4Search in Google Scholar PubMed

Dennys, C.N., Armstrong, J., Levy, M., Byun, Y.J., Ramdial, K.R., Bott, M., Rossi, F.H., Fernández-Valle, C., Franco, M.C., and Estevez, A.G. (2015). Chronic inhibitory effect of riluzole on trophic factor production. Exp Neurol. 271, 301–307.10.1016/j.expneurol.2015.05.016Search in Google Scholar PubMed PubMed Central

Deutschenbaur, L., Beck, J., Kiyhankhadiv, A., Mühlhauser, M., Borgwardt, S., Walter, M., Hasler, G., Sollberger, D., and Lang, U.E. (2016). Role of calcium, glutamate and NMDA in major depression and therapeutic application. Prog. Neuropsychopharmacol. Biol. Psychiatry 64, 325–333.10.1016/j.pnpbp.2015.02.015Search in Google Scholar PubMed

Di Benedetto, B., Kühn, R., Nothdurfter, C., Rein, T., Wurst, W., and Rupprecht, R. (2012). N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant. Neuropharmacology 62, 209–216.10.1016/j.neuropharm.2011.07.001Search in Google Scholar PubMed

Diniz, B.S., Teixeira, A.L., Miranda, A.S., Talib, L.L., Gattaz, W.F., and Forlenza, O.V. (2012). Circulating Glial-derived neurotrophic factor is reduced in late-life depression. J. Psychiatr. Res. 46, 135–139.10.1016/j.jpsychires.2011.09.007Search in Google Scholar PubMed

Dixon, J.F. and Hokin, L.E. (1998). Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 95, 8363–838.10.1073/pnas.95.14.8363Search in Google Scholar PubMed PubMed Central

Ducray, A., Krebs, S.H., Schaller, B., Seiler, R.W., Meyer, M., and Widmer, H.R. (2006). GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon. Brain Res. 1069, 104–112.10.1016/j.brainres.2005.11.056Search in Google Scholar PubMed

Duman, R.S. and Monteggia, L.M. (2006). A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116–1127.10.1016/j.biopsych.2006.02.013Search in Google Scholar PubMed

Emamghoreishi, M., Keshavarz, M., and Nekooeian, A.A. (2015). Acute and chronic effects of lithium on BDNF and GDNF mRNA and protein levels in rat primary neuronal, astroglial and neuroastroglia cultures. Iran. J. Basic Med. Sci. 18, 240–246.Search in Google Scholar

Farrand, A.Q., Gregory, R.A., Scofield, M.D., Helke, K.L., and Boger H.A. (2015). Effects of aging on glutamate neurotransmission in the substantia nigra of GDNF heterozygous mice. Neurobiol. Aging 36, 1569–1576.10.1016/j.neurobiolaging.2014.11.017Search in Google Scholar PubMed PubMed Central

Fonseca, C.P., Gama, S., Saavedra, A., and Baltazar, G. (2014). H₂O₂- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways. Biochim. Biophys. Acta 1842, 927–934.10.1016/j.bbadis.2014.03.003Search in Google Scholar PubMed

Golan, M., Schreiber, G., and Avissar, S. (2011). Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway. Int. J. Neuropsychopharmacol. 14, 1289–1300.10.1017/S1461145710001550Search in Google Scholar PubMed

Göttlicher, M., Minucci, S., Zhu, P., Krämer, O.H., Schimpf, A., Giavara, S., Sleeman, J.P., Lo Coco, F., Nervi, C., Pelicci, P.G., et al. (2001). Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20, 6969–6978.10.1093/emboj/20.24.6969Search in Google Scholar PubMed PubMed Central

Hamon, M. and Blier, P. (2013). Monoamine neurocircuitry in depression and strategies for new treatments. Prog. Neuropsychopharmacol. Biol. Psychiatry 45, 54–63.10.1016/j.pnpbp.2013.04.009Search in Google Scholar PubMed

Heberlein, A., Lenz, B., Muschler, M., Frieling, H., Buechl, R., Gröschl, M., Kornhuber, J., Bleich, S., and Hillemacher, T. (2010). BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence. Psychopharmacology (Berl.) 209, 213–215.10.1007/s00213-010-1781-3Search in Google Scholar PubMed

Henkel, A.W., Alali, H., Devassy, A., Alawadi, M.M., and Redzic, Z.B. (2014). Antagonistic interactions between dexamethasone and fluoxetine modulate morphodynamics and expression of cytokines in astrocytes. Neuroscience 280, 318–327.10.1016/j.neuroscience.2014.09.012Search in Google Scholar PubMed

Hidalgo-Figueroa, M., Bonilla, S., Gutiérrez, F., Pascual, A., and López-Barneo, J. (2012). GDNF is predominantly expressed in the PV+ neostriatal interneuronal ensemble in normal mouse and after injury of the nigrostriatal pathway. J. Neurosci. 18, 864–872.10.1523/JNEUROSCI.2693-11.2012Search in Google Scholar PubMed PubMed Central

Hisaoka, K., Nishida, A., Koda, T., Miyata, M., Zensho, H., Morinobu, S., Ohta, M., and Yamawaki, S. (2001). Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J. Neurochem. 79, 25–34.10.1046/j.1471-4159.2001.00531.xSearch in Google Scholar PubMed

Hisaoka, K., Nishida, A., Takebayashi, M., Koda, T., Yamawaki, S., and Nakata, Y. (2004). Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Res. 1002, 167–170.10.1016/j.brainres.2004.01.009Search in Google Scholar PubMed

Hisaoka, K., Takebayashi, M., Tsuchioka, M., Maeda, N., Nakata, Y., and Yamawaki, S. (2007). Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J. Pharmacol. Exp. Ther. 321, 148–157.10.1124/jpet.106.116558Search in Google Scholar

Hisaoka, K., Maeda, N., Tsuchioka, M., and Takebayashi, M. (2008). Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production. Brain Res. 1196, 53–58.10.1016/j.brainres.2007.12.019Search in Google Scholar

Hisaoka, K., Tsuchioka, M., Yano, R., Maeda, N., Kajitani, N., Morioka, N., Nakata, Y., and Takebayashi, M. (2011). Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production. J. Biol. Chem. 286, 21118–21128.10.1074/jbc.M111.224683Search in Google Scholar

Hisaoka-Nakashima, K., Miyano, K., Matsumoto, C., Kajitani, N., Abe, H., Okada-Tsuchioka, M., Yokoyama, A., Uezono, Y., Morioka, N., Nakata, Y., et al. (2015). Tricyclic antidepressant amitriptyline-induced glial cell line-derived neurotrophic factor production involves pertussis toxin-sensitive Gα_i/o activation in astroglial cells. J. Biol. Chem. 290, 13678–13691.10.1074/jbc.M114.622415Search in Google Scholar

Ho, A., Gore, A.C., Weickert, C.S., and Blum, M. (1995). Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. Neuroreport 6, 1454–1458.10.1097/00001756-199507100-00023Search in Google Scholar

Huang, L., Guo, H., Hellard, D.T., and Katz, D.M. (2005). Glial cell line-derived neurotrophic factor (GDNF) is required for differentiation of pontine noradrenergic neurons and patterning of central respiratory output. Neuroscience 130, 95–105.10.1016/j.neuroscience.2004.08.036Search in Google Scholar

Ibáñez, C.F. and Andressoo, J.O. (2017). Biology of GDNF and its receptors – relevance for disorders of the central nervous system. Neurobiol. Dis. 97, 80–89.10.1016/j.nbd.2016.01.021Search in Google Scholar

Igarashi, Y., Chiba, H., Utsumi, H., Miyajima, H., Ishizaki, T., Gotoh, T., Kuwahara, K., Tobioka, H., Satoh, M., Mori, M., et al. (2000). Expression of receptors for glial cell line-derived neurotrophic factor (GDNF) and neurturin in the inner blood-retinal barrier of rats. Cell. Struct. Funct. 25, 237–241.10.1247/csf.25.237Search in Google Scholar

Irala, D., Bonafina, A., Fontanet, P.A., Alsina, F.C., Paratcha, G., and Ledda, F. (2016). GDNF/GFRα1 complex promotes development of hippocampal dendritic arbors and spines via NCAM. Development. 143, 4224–4235.10.1242/dev.140350Search in Google Scholar

Junker, V., Becker, A., Hühne, R., Zembatov, M., Ravati, A., Culmsee, C., and Krieglstein, J. (2002). Stimulation of β-adrenoceptors activates astrocytes and provides neuroprotection. Eur. J. Pharmacol. 446, 25–36.10.1016/S0014-2999(02)01814-9Search in Google Scholar

Kastin, A.J., Akerstrom, V., and Pan, W. (2003). Glial cell line-derived neurotrophic factor does not enter normal mouse brain. Neurosci. Lett. 340, 239–241.10.1016/S0304-3940(03)00007-7Search in Google Scholar

Kessler, R.C., Merikangas, K.R., and Wang P.S. (2007). Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu. Rev. Clin. Psychol. 3, 137–158.10.1146/annurev.clinpsy.3.022806.091444Search in Google Scholar PubMed

Kholodilov, N., Yarygina, O., Oo, T.F., Zhang, H., Sulzer, D., Dauer, W., and Burke, R.E. (2004). Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J. Neurosci. 24, 3136–3146.10.1523/JNEUROSCI.4506-03.2004Search in Google Scholar PubMed PubMed Central

Kholodilov, N., Kim, S.R., Yarygina, O., Kareva, T., Cho, J.W., Baohan, A., and Burke, R.E. (2011). Glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra. J. Neurochem. 116, 486–498.10.1111/j.1471-4159.2010.07128.xSearch in Google Scholar PubMed PubMed Central

Kopra, J., Vilenius, C., Grealish, S., Härma, M.A., Varendi, K., Lindholm, J., Castrén, E., Võikar, V., Björklund, A., Piepponen, T.P., et al. (2015). GDNF is not required for catecholaminergic neuron survival in vivo. Nat. Neurosci. 18, 319–322.10.1038/nn.3941Search in Google Scholar PubMed PubMed Central

Kotyuk, E., Keszler, G., Nemeth, N., Ronai, Z., Sasvari-Szekely, M., and Szekely, A. (2013). Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety. PLoS One 8, e80613.10.1371/journal.pone.0080613Search in Google Scholar PubMed PubMed Central

Kramer, E.R. and Liss, B. (2015). GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. FEBS Lett. 589, 3760–3772.10.1016/j.febslet.2015.11.006Search in Google Scholar PubMed

Kuric, E., Wieloch, T., and Ruscher, K. (2013). Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke. Exp. Neurol. 247, 202–208.10.1016/j.expneurol.2013.04.016Search in Google Scholar PubMed

Ledda, F., Paratcha, G., Sandoval-Guzmán, T., and Ibáñez, C.F. (2007). GDNF and GFRα1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat. Neurosci. 10, 293–300.10.1038/nn1855Search in Google Scholar PubMed

Lee, B.H., Hong, J.P., Hwang, J.A., Na, K.S., Kim, W.J., Trigo, J., and Kim, Y.K. (2016). Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: a preliminary study. Acta Neuropsychiatr. 28, 45–50.10.1017/neu.2015.42Search in Google Scholar PubMed

Lin, P.Y. and Tseng, P.T. (2015). Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study. J. Psychiatr. Res. 63, 20–27.10.1016/j.jpsychires.2015.02.004Search in Google Scholar PubMed

Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130–1132.10.1126/science.8493557Search in Google Scholar PubMed

Liu, Q., Zhu, H.Y., Li, B., Wang, Y.Q., Yu, J., and Wu, G.C. (2012). Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression. J. Affect. Disord. 141, 367–372.10.1016/j.jad.2012.03.018Search in Google Scholar PubMed

Lv, L., Han, X., Sun, Y., Wang, X., and Dong. Q. (2012). Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro. Exp Neurol. 233, 783–790.10.1016/j.expneurol.2011.11.042Search in Google Scholar PubMed PubMed Central

Ma, X.C., Chen, C., Zhu, F., Jia, W., and Gao, C.G. (2013). Association of the GDNF gene with depression and heroin dependence, but not schizophrenia, in a Chinese population. Psychiatry Res. 210, 1296–1298.10.1016/j.psychres.2013.08.025Search in Google Scholar PubMed

Maheu, M., Lopez, J.P., Crapper, L., Davoli, M.A., Turecki, G., and Mechawar, N. (2015). MicroRNA regulation of central glial cell line-derived neurotrophic factor (GDNF) signalling in depression. Transl. Psychiatry 5, e511.10.1038/tp.2015.11Search in Google Scholar PubMed PubMed Central

Maragakis, N.J. and Rothstein, J.D. (2006). Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2, 679–689.10.1038/ncpneuro0355Search in Google Scholar PubMed

Marksteiner, J., Kemmler, G., Weiss, E.M., Knaus, G., Ullrich, C., Mechtcheriakov, S., Oberbauer, H., Auffinger, S., Hinterhölzl, J., Hinterhuber, H., et al. (2011). Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol. Aging 32, 539–540.10.1016/j.neurobiolaging.2009.03.011Search in Google Scholar PubMed PubMed Central

Maruyama, W. and Naoi, M. (2013). “70th Birthday Professor Riederer” induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy?. J. Neural Transm. (Vienna) 120, 83–89.10.1007/s00702-012-0876-xSearch in Google Scholar PubMed

Maruyama, W., Nitta, A., Shamoto-Nagai, M., Hirata, Y., Akao, Y., Yodim, M., Furukawa, S., Nabeshima, T., and Naoi, M. (2004). N-propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-κB transcription factor. Neurochem. Int. 44, 393–400.10.1016/j.neuint.2003.08.005Search in Google Scholar PubMed

McEwen, B.S., Bowles, N.P., Gray, J.D., Hill, M.N., Hunter, R.G., Karatsoreos, I.N., and Nasca, C. (2015). Mechanisms of stress in the brain. Nat. Neurosci. 18, 1353–1363.10.1038/nn.4086Search in Google Scholar

Ménard, C., Hodes, G.E., and Russo, S.J. (2016). Pathogenesis of depression: Insights from human and rodent studies. Neuroscience 321, 138–162.10.1016/j.neuroscience.2015.05.053Search in Google Scholar

Menegola, E., Broccia, M.L., Di Renzo, F., Massa, V., and Giavini, E. (2004). Effects of excess and deprivation of serotonin on in vitro neuronal differentiation. In Vitro Cell. Dev. Biol. Anim. 40, 52–56.10.1290/1543-706X(2004)40<52:EOEADO>2.0.CO;2Search in Google Scholar

Mercier, G., Lennon, A.M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., and Pierre, M. (2004). MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J. Mol. Neurosci. 24, 207–216.10.1385/JMN:24:2:207Search in Google Scholar

Michel, T.M., Frangou, S., Thiemeyer, D., Camara, S., Jecel, J., Nara, K., Brunklaus, A., Zoechling R., and Riederer P. (2007). Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder – a postmortem study. Psychiatry Res. 151, 145–150.10.1016/j.psychres.2006.04.013Search in Google Scholar

Michel, T.M., Frangou, S., Camara, S., Thiemeyer, D., Jecel, J., Tatschner, T., Zoechling, R., and Grünblatt, E. (2008). Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur. Psychiatry 23, 413–420.10.1016/j.eurpsy.2008.06.001Search in Google Scholar

Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., and Kuno, S. (2000). Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes. Biochem. Biophys. Res. Commun. 279, 751–755.10.1006/bbrc.2000.4037Search in Google Scholar

Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., and Kuno, S. (2001). Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neurosci. Lett. 310, 117–120.10.1016/S0304-3940(01)02098-5Search in Google Scholar

Najjar, S., Pearlman, D.M., Devinsky, O., Najjar, A., and Zagzag, D. (2013). Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J. Neuroinflamm. 10, 142.10.1186/1742-2094-10-142Search in Google Scholar

Nakashima, S., Matsuyama, Y., Yu, Y., Kiuchi, K., and Ishiguro, N. (2004). Suppression of GDNF production by MPSS treatment following spinal cord injury in the rat. Neuroreport 15, 2337–2340.10.1097/00001756-200410250-00007Search in Google Scholar

Naoi, M. and Maruyama, W. (2009). Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease. Expert Rev. Neurother. 9, 1233–1250.10.1586/ern.09.68Search in Google Scholar PubMed

Naoi, M., Maruyama, W., and Inaba-Hasegawa, K. (2013). Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms. Expert Rev. Neurother. 13, 671–684.10.1586/ern.13.60Search in Google Scholar PubMed

Naumenko, V.S., Bazovkina, D.V., Semenova, A.A., Tsybko, A.S., Il’chibaeva, T.V., Kondaurova, E.M., and Popova, N.K. (2013). Effect of glial cell line-derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders. J. Neurosci. Res. 91, 1628–1638.10.1002/jnr.23286Search in Google Scholar PubMed

Naumenko, V.S., Kondaurova, E.M., Bazovkina, D.V., Tsybko, A.S., Ilchibaeva, T.V., Khotskin, N.V., Semenova, A.A., and Popova, N.K. (2014). Effect of GDNF on depressive-like behavior, spatial learning and key genes of the brain dopamine system in genetically predisposed to behavioral disorders mouse strains. Behav. Brain Res. 274, 1–9.10.1016/j.bbr.2014.07.045Search in Google Scholar PubMed

Nishikiori, N., Osanai, M., Chiba, H., Kojima, T., Mitamura, Y., Ohguro, H., and Sawada, N. (2007). Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy. Diabetes 56, 1333–1340.10.2337/db06-1431Search in Google Scholar PubMed

Otsuki, K., Uchida, S., Watanuki, T., Wakabayashi, Y., Fujimoto, M., Matsubara, T., Funato, H., and Watanabe, Y. (2008). Altered expression of neurotrophic factors in patients with major depression. J. Psychiatr. Res. 42, 1145–1153.10.1016/j.jpsychires.2008.01.010Search in Google Scholar PubMed

Pallavi, P., Sagar, R., Mehta, M., Sharma, S., Subramanium, A., Shamshi, F., Sengupta, U., Qadri, R., Pandey, R.M., and Mukhopadhyay, A.K. (2013). Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity. J. Affect. Disord. 150, 415–423.10.1016/j.jad.2013.04.033Search in Google Scholar PubMed

Pascual, A., Hidalgo-Figueroa, M., Gómez-Díaz, R., and López-Barneo, J. (2011). GDNF and protection of adult central catecholaminergic neurons. J. Mol. Endocrinol. 46, R83–R92.10.1530/JME-10-0125Search in Google Scholar PubMed

Paumier, K.L., Sortwell, C.E., Madhavan, L., Terpstra, B., Celano, S.L., Green, J.J., Imus, N.M., Marckini, N., Daley, B., Steece-Collier, K., et al. (2015a). Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of Parkinsonism. Neuropsychopharmacology 40, 874–883.10.1038/npp.2014.262Search in Google Scholar PubMed PubMed Central

Paumier, K.L., Sortwell, C.E., Madhavan, L., Terpstra, B., Daley, B.F., and Collier, T.J. (2015b). Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system. Exp Neurol. 266, 11–21.10.1016/j.expneurol.2015.02.005Search in Google Scholar PubMed PubMed Central

Pehrson, A.L. and Sanchez, C. (2015). Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug. Des. Dev. Ther. 9, 603–624.10.2147/DDDT.S62912Search in Google Scholar PubMed PubMed Central

Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G., Lazar, M.A., and Klein, P.S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734–36741.10.1074/jbc.M101287200Search in Google Scholar PubMed

Pruett, B.S. and Salvatore, M.F. (2013). Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity. Mol. Neurobiol. 47, 988–999.10.1007/s12035-013-8397-7Search in Google Scholar PubMed PubMed Central

Quintero, E.M., Willis, L.M., Zaman, V., Lee, J., Boger, H.A., Tomac, A., Hoffer, B.J., Strömberg, I., and Granholm, A.C. (2004). Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway. Neuroscience 124, 137–146.10.1016/j.neuroscience.2003.11.001Search in Google Scholar PubMed

Rajkowska, G. and Stockmeier, C.A. (2013). Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets 14, 1225–1236.10.2174/13894501113149990156Search in Google Scholar PubMed PubMed Central

Roberts, R.J., Lohano, K.K., and El-Mallakh, R.S. (2016). Antipsychotics as antidepressants. Asia Pac. Psychiatry. 8, 179–188.10.1111/appy.12186Search in Google Scholar PubMed

Rocha, S.M., Cristovão, A.C., Campos, F.L., Fonseca, C.P., and Baltazar, G. (2012). Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiol. Dis. 47, 407–415.10.1016/j.nbd.2012.04.014Search in Google Scholar PubMed

Rosa, A.R., Frey, B.N., Andreazza, A.C., Ceresér, K.M., Cunha, A.B., Quevedo, J., Santin, A., Gottfried, C., Gonçalves, C.A., Vieta, E., et al. (2006). Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci. Lett. 407, 146–150.10.1016/j.neulet.2006.08.026Search in Google Scholar PubMed

Rybakowski, J.K., Permoda-Osip, A., Skibinska, M., Adamski, R., and Bartkowska-Sniatkowska, A. (2013). Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? Hum. Psychopharmacol. 28, 87–90.10.1002/hup.2271Search in Google Scholar PubMed

Saavedra, A., Baltazar, G., and Duarte, E.P. (2008). Driving GDNF expression: the green and the red traffic lights. Prog. Neurobiol. 86, 186–215.10.1016/j.pneurobio.2008.09.006Search in Google Scholar PubMed

Salardini, E., Zeinoddini, A., Mohammadinejad, P., Khodaie-Ardakani, M.R., Zahraei, N., Zeinoddini, A., and Akhondzadeh, S. (2016). Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial. J. Psychiatr. Res. 75, 24–30.10.1016/j.jpsychires.2016.01.003Search in Google Scholar PubMed

Salvatore, M.F., Zhang, J.L., Large, D.M., Wilson, P.E., Gash, C.R., Thomas, T.C., Haycock, J.W., Bing, G., Stanford, J.A., Gash, D.M., et al. (2004). Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. J. Neurochem. 90, 245–254.10.1111/j.1471-4159.2004.02496.xSearch in Google Scholar PubMed

Sariola, H. and Saarma, M. (2003). Novel functions and signalling pathways for GDNF. J. Cell. Sci. 116, 3855–3862.10.1242/jcs.00786Search in Google Scholar PubMed

Semenova, A.A., Bazovkina, D.B., Tsybko, A.S., Naumenko, V.S., and Popova, N.K. (2013). Effect of GDNF on the behavior of ASC mice with high hereditary predisposition to catalepsy. Zh. Vyssh. Nerv. Deiat. Im. I.P. Pavlova. 63, 495–501.10.7868/S0044467713040102Search in Google Scholar

Shao, Z., Dyck, L.E., Wang, H., and Li, X.M. (2006). Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. J. Psychiatry Neurosci. 31, 32–37.Search in Google Scholar

Shimizu, F., Sano, Y., Saito, K., Abe, M.A., Maeda, T., Haruki, H., and Kanda, T. (2012). Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem. Res. 37, 401–409.10.1007/s11064-011-0626-8Search in Google Scholar PubMed

Sidorova, Y.A. and Saarma, M. (2016). Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential. Mol. Biol. (Mosk.) 50, 589–598.10.1134/S0026893316040105Search in Google Scholar

Suppes, T., Datto, C., Minkwitz, M., Nordenhem, A., Walker, C., and Darko, D. (2010). Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J. Affect. Disord. 121, 106–115.10.1016/j.jad.2009.10.007Search in Google Scholar PubMed

Takebayashi, M., Hisaoka, K., Nishida, A., Tsuchioka, M., Miyoshi, I., Kozuru, T., Hikasa, S., Okamoto, Y., Shinno, H., Morinobu, S., et al. (2006). Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int. J. Neuropsychopharmacol. 9, 607–612.10.1017/S1461145705006085Search in Google Scholar PubMed

Torres-Platas, S.G., Hercher, C., Davoli, M.A., Maussion, G., Labonté, B., Turecki, G., and Mechawar, N. (2011). Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 36, 2650–2658.10.1038/npp.2011.154Search in Google Scholar PubMed PubMed Central

Tseng, P.T., Lee, Y., and Lin, P.Y. (2013). Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 334–339.10.1016/j.pnpbp.2012.09.009Search in Google Scholar PubMed

Tsuchioka, M., Takebayashi, M., Hisaoka, K., Maeda, N., and Nakata, Y. (2008). Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J. Neurochem. 106, 244–257.10.1111/j.1471-4159.2008.05357.xSearch in Google Scholar

Tsuchioka, M., Hisaoka, K., Yano, R., Shibasaki, C., Kajiatani, N., and Takebayashi, M. (2011). Riluzole-induced glial cell line-derived neurotrophic factor production is regulated through fibroblast growth factor receptor signaling in rat C6 glioma cells. Brain Res. 1384, 1–8.10.1016/j.brainres.2011.01.100Search in Google Scholar

Tsybko, A.S., Il’chibaeva, T.V., Kondaurova, E.M., Bazovkina, D.V., and Naumenko, V.S. (2014). The effect of central administration of the neurotrophic factors BDNF and GDNF on the functional activity and expression of the serotonin 5-HT2A receptors in mice genetically predisposed to depressive-like behavior. Mol. Biol. (Mosk) 48, 983–989.10.1134/S0026893314060181Search in Google Scholar

Tunca, Z., Ozerdem, A., Ceylan, D., Yalçın, Y., Can, G., Resmi, H., Akan, P., Ergör, G., Aydemir, O., Cengisiz, C., et al. (2014a). Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: the role of lithium. J. Affect. Disord. 166, 193–200.10.1016/j.jad.2014.05.012Search in Google Scholar

Tunca, Z., Bayn, M., Alkn, T., Özerdem, A., Resmi, H., and Akan, P. (2014b). A preliminary observation of increased glial cell line-derived neurotrophic factor in manic switch due to electroconvulsive treatment in depressive patients. J. ECT 31, 167–172.10.1097/YCT.0000000000000198Search in Google Scholar

Tunca, Z., Kıvırcık Akdede, B., Özerdem, A., Alkın, T., Polat, S., Ceylan, D., Bayın, M., Cengizçetin Kocuk, N., Şimşek, S., Resmi, H., et al. (2015). Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders. Eur. Psychiatry 30, 198–204.10.1016/j.eurpsy.2014.11.003Search in Google Scholar

Uchida, S., Hara, K., Kobayashi, A., Otsuki, K., Yamagata, H., Hobara, T., Suzuki, T., Miyata, N., and Watanabe, Y. (2011). Epigenetic status of GDNF in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69, 359–372.10.1016/j.neuron.2010.12.023Search in Google Scholar

Utsumi, H., Chiba, H., Kamimura, Y., Osanai, M., Igarashi, Y., Tobioka, H., Mori, M., and Sawada, N. (2000). Expression of GFRα-1, receptor for GDNF, in rat brain capillary during postnatal development of the BBB. Am. J. Physiol. Cell. Physiol. 279, C361–C368.10.1152/ajpcell.2000.279.2.C361Search in Google Scholar

Varela, R.B., Valvassori, S.S., Lopes-Borges, J., Mariot, E., Dal-Pont, G.C., Amboni, R.T., Bianchini, G., and Quevedo, J. (2015). Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats. J. Psychiatr. Res. 61, 114–121.10.1016/j.jpsychires.2014.11.003Search in Google Scholar

Verity, A.N., Wyatt, T.L., Lee, W., Hajos, B., Baecker, P.A., Eglen, R.M., and Johnson R.M. (1999). Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J. Neurosci. Res. 55, 187–197.10.1002/(SICI)1097-4547(19990115)55:2<187::AID-JNR6>3.0.CO;2-TSearch in Google Scholar

Wang, X., Hou, Z., Yuan, Y., Hou, G., Liu, Y., Li, H., and Zhang, Z. (2011). Association study between plasma GDNF and cognitive function in late-onset depression. J. Affect. Disord. 132, 418–421.10.1016/j.jad.2011.03.043Search in Google Scholar PubMed

Wang, X.C., Xu, D.J., Chen, G.H., Xia, Q., and Liu, L.N. (2014). Association of 2 neurotrophic factor polymorphisms with efficacy of paroxetine in patients with major depressive disorder in a Chinese population. Ther. Drug Monit. 36, 612–617.10.1097/FTD.0000000000000062Search in Google Scholar PubMed

Wu, X., Chen, P.S., Dallas, S., Wilson, B., Block, M.L., Wang, C.C., Kinyamu, H., Lu, N., Gao, X., Leng, Y., et al. (2008). Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int. J. Neuropsychopharmacol. 11, 1123–1134.10.1017/S1461145708009024Search in Google Scholar PubMed PubMed Central

Yamagata, K., Tagami, M., Ikeda, K., Tsumagari, S., Yamori, Y., and Nara, Y. (2002). Differential regulation of glial cell line-derived neurotrophic factor (GDNF) mRNA expression during hypoxia and reoxygenation in astrocytes isolated from stroke-prone spontaneously hypertensive rats. Glia 37, 1–7.10.1002/glia.10003Search in Google Scholar PubMed

Zaman, V., Li, Z., Middaugh, L., Ramamoorthy, S., Rohrer, B., Nelson, M.E., Tomac, A.C., Hoffer, B.J., Gerhardt, G.A., and Granholm, A.Ch. (2003). The noradrenergic system of aged GDNF heterozygous mice. Cell Transplant. 12, 291–303.10.3727/000000003108746740Search in Google Scholar PubMed

Zhang, X., Zhang, Z., Xie, C., Xi, G., Zhou, H., Zhang, Y., and Sha, W. (2008). Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 886–890.10.1016/j.pnpbp.2008.01.004Search in Google Scholar PubMed

Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H., and Zhang, Y. (2009). Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Res. 170, 273–275.10.1016/j.psychres.2009.01.011Search in Google Scholar PubMed

Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H., and Zhang, Y. (2010). Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. J. Affect. Disord. 126, 326–329.10.1016/j.jad.2010.03.003Search in Google Scholar PubMed

Zhang, X., Ru, B., Sha, W., Xin, W., Zhou, H., and Zhang, Y. (2014). Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder. Asia Pac. Psychiatry 6, 302–307.10.1111/appy.12120Search in Google Scholar PubMed